| John R Schneeweis, MD | |
|
165 Mill St, Leominster, MA 01453 | |
| (978) 466-3208 | |
| (978) 840-1680 |
| Full Name | John R Schneeweis |
|---|---|
| Gender | Male |
| Speciality | Family Practice |
| Experience | 38 Years |
| Location | 165 Mill St, Leominster, Massachusetts |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1023065455 | NPI | - | NPPES |
| 042472266 | Other | HEALTHCARE VALUE MANAGMEN | |
| 26998 | Other | HEALTHY START | |
| AA1224 | Other | HARVARD PILGRIM HEALTHCAR | |
| 042472266 | Other | ONE HEALTH PLAN | |
| 26998 | Other | CHILDRENS MEDICAL SECURIT | |
| 5884434 | Other | AETNA US HEALTHCARE | |
| 784185 | Other | MVP HEALTH CARE | |
| J08904 | Other | BLUE CARE ELECT | |
| J08904 | Other | BLUE SHIELD INDEMNITY | |
| 0100294 | Other | EVERCARE | |
| 3521498 | Other | CIGNA HEALTH PLAN | |
| J08904 | Other | MEDICARE B | |
| 3103820 | Medicaid | MA | |
| 9900287 | Other | FALLON COMMUNITY HEALTH P | |
| J08904 | Other | BLUE SHIELD HMO BLUE | |
| 3103820 | Other | MEDICAID WELFARE | |
| 042472266 | Other | PRIVATE HEALTHCARE SYSTEM | |
| 1150309 | Other | FIRST HEALTH |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | 58233 (Massachusetts) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Vna Care Network | Worcester, MA | Home health agency |
| Health Alliance Home Health And Hospice | Leominster, MA | Home health agency |
| Healthalliance Hospitals, Inc | Leominster, MA | Hospital |
| Umass Memorial Medical Center/university Campus | Worcester, MA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Reliant Medical Group Inc | 5597755322 | 543 |
News Archive
Continued opposition to the overhaul is one of the administration's biggest challenges. In addition, many consumers eligible to buy insurance in new online marketplaces still don't understand their benefits and obligations under the law. Meanwhile, insurance companies are gearing up to sell policies.
Children exposed in the womb to the widely used pesticide additive piperonyl butoxide (PBO) have heightened risk of noninfectious cough at ages 5 and 6, according to researchers at the Columbia Center for Children's Environmental Health (CCCEH) at the Mailman School of Public Health and of Columbia University Medical Center.
Data from four pivotal Phase III clinical trials demonstrate that linagliptin achieved statistically significant and sustained reductions in blood sugar as measured by hemoglobin A1c, fasting plasma glucose and postprandial glucose. Boehringer Ingelheim Pharmaceuticals, Inc. is investigating the dipeptidyl peptidase 4 inhibitor as an oral once-daily tablet, as monotherapy and combination therapy, to treat type 2 diabetes.
Spain is leading the world in deceased organ donation. A new article published in the American Journal of Transplantation contains important information that can help other countries learn from the success of the Spanish system to help address the worldwide problem of transplant organ shortages.
A new frontier in the science of circadian rhythms - whose disruption is linked to major diseases like cancer and diabetes - suggests a previously unknown mechanism at work in our daily biological cycle.
› Verified 8 days ago
| Entity Name | Reliant Medical Group Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1720017528 PECOS PAC ID: 5597755322 Enrollment ID: O20040708000650 |
News Archive
Continued opposition to the overhaul is one of the administration's biggest challenges. In addition, many consumers eligible to buy insurance in new online marketplaces still don't understand their benefits and obligations under the law. Meanwhile, insurance companies are gearing up to sell policies.
Children exposed in the womb to the widely used pesticide additive piperonyl butoxide (PBO) have heightened risk of noninfectious cough at ages 5 and 6, according to researchers at the Columbia Center for Children's Environmental Health (CCCEH) at the Mailman School of Public Health and of Columbia University Medical Center.
Data from four pivotal Phase III clinical trials demonstrate that linagliptin achieved statistically significant and sustained reductions in blood sugar as measured by hemoglobin A1c, fasting plasma glucose and postprandial glucose. Boehringer Ingelheim Pharmaceuticals, Inc. is investigating the dipeptidyl peptidase 4 inhibitor as an oral once-daily tablet, as monotherapy and combination therapy, to treat type 2 diabetes.
Spain is leading the world in deceased organ donation. A new article published in the American Journal of Transplantation contains important information that can help other countries learn from the success of the Spanish system to help address the worldwide problem of transplant organ shortages.
A new frontier in the science of circadian rhythms - whose disruption is linked to major diseases like cancer and diabetes - suggests a previously unknown mechanism at work in our daily biological cycle.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| John R Schneeweis, MD 630 Plantation St, Worcester, MA 01605 Ph: (978) 466-3208 | John R Schneeweis, MD 165 Mill St, Leominster, MA 01453 Ph: (978) 466-3208 |
News Archive
Continued opposition to the overhaul is one of the administration's biggest challenges. In addition, many consumers eligible to buy insurance in new online marketplaces still don't understand their benefits and obligations under the law. Meanwhile, insurance companies are gearing up to sell policies.
Children exposed in the womb to the widely used pesticide additive piperonyl butoxide (PBO) have heightened risk of noninfectious cough at ages 5 and 6, according to researchers at the Columbia Center for Children's Environmental Health (CCCEH) at the Mailman School of Public Health and of Columbia University Medical Center.
Data from four pivotal Phase III clinical trials demonstrate that linagliptin achieved statistically significant and sustained reductions in blood sugar as measured by hemoglobin A1c, fasting plasma glucose and postprandial glucose. Boehringer Ingelheim Pharmaceuticals, Inc. is investigating the dipeptidyl peptidase 4 inhibitor as an oral once-daily tablet, as monotherapy and combination therapy, to treat type 2 diabetes.
Spain is leading the world in deceased organ donation. A new article published in the American Journal of Transplantation contains important information that can help other countries learn from the success of the Spanish system to help address the worldwide problem of transplant organ shortages.
A new frontier in the science of circadian rhythms - whose disruption is linked to major diseases like cancer and diabetes - suggests a previously unknown mechanism at work in our daily biological cycle.
› Verified 8 days ago
Brittany Martinez, MD Family Medicine Medicare: Medicare Enrolled Practice Location: 165 Mill St, Leominster, MA 01453 Phone: 978-878-8100 | |
Thomas J Scornavacca, D.O. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 50 Memorial Dr, Suite 103, Leominster, MA 01453 Phone: 978-534-8607 | |
Ms. Michelle D Dion, CPNP Family Medicine Medicare: Medicare Enrolled Practice Location: 100 Hospital Rd Fl 4, Leominster, MA 01453 Phone: 978-514-6300 Fax: 978-534-0281 | |
Dr. Joseph R Difranza, M.D. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 225 New Lancaster Rd, Leominster, MA 01453 Phone: 978-466-3208 Fax: 978-840-1680 | |
Erin K Dooley, MD/MPH Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 87 N Main St, Leominster, MA 01453 Phone: 978-534-8701 Fax: 978-534-8705 | |
Dr. Elizabeth Burbank, M.D. Family Medicine Medicare: Medicare Enrolled Practice Location: 25 Tucker Dr, Leominster, MA 01453 Phone: 978-728-0621 Fax: 978-728-0656 |